Latest Breaking News On - Tenapanor treatment - Page 1 : vimarsana.com

Ardelyx (ARDX) Reports Positive Data from Studies of XPHOZAH

Ardelyx (ARDX) Reports Positive Data from Studies of XPHOZAH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDerek forfangDavid spiegelTenapanor monotherapyLaura williamsArnold silvaDrug administration onAmerican society of nephrologyBoise kidney hypertension instituteArdelyx incPennsylvania convention centerArdelyx patient advisory councilAmerican societyKidney weekExhibitor spotlightDrug administration

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesArnold silvaTenapanor monotherapyFosun pharmaDerek forfangDavid spiegelLaura williamsCaitlin lowieKimia keshtbodBoise kidney hypertension instituteArdelyx incPennsylvania convention centerArdelyx patient advisory councilAmerican society of nephrologyDrug administration onAmerican society

Ardelyx (ARDX) Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH

Ardelyx (ARDX) Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCaitlin lowieLaura williamsFosun pharmaKimia keshtbodArdelyx incNational kidney foundationExchange commissionExchange commission onClinical meetingsHoc analysesSerum phosphate changesAfrican americanWhite patientsIn depth analysisTenapanor treatment

Ardelyx Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH® (tenapanor) at National Kidney Foundation 2023 Spring Clinical Meetings

Three posters support the important role that XPHOZAH, a novel phosphate absorption inhibitor, could potentially play in the treatment of hyperphosphatemia XPHOZAH consistently lowered serum. | April 12, 2023

United statesFosun pharmaLaura williamsExchange commissionNational kidney foundationExchange commission onArdelyx incClinical meetingsHoc analysesSerum phosphate changesAfrican americanWhite patientsIn depth analysisTenapanor treatmentChronic kidney diseaseKyowa kirin